CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Shares withheld for taxes EVP & Chief R & QA Officer gave up 3,604 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Strategy Officer gave up 1,456 shares (to pay taxes)
- 4 Open-market sale EVP & Chief Financial Officer sold 13,000 shares at an average $47.07 ($611,925)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $46.92 ($938,459)
- 4 Open-market sale Chief Executive Officer sold 20,000 shares at an average $46.80 ($935,956)
- 4 Open-market sale Former EVP, GC & Sec. sold 12,214 shares at an average $38.01 ($464,210)
- 4 Shares withheld for taxes EVP & Chief R & QA Officer gave up 3,704 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, R&D & Chief Scientific Of gave up 4,925 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Strategy Officer gave up 4,169 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 4,819 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 8,800 shares at an average $37.44 ($329,429)
- 4 Shares withheld for taxes EVP, General Counsel & Sec. gave up 4,434 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, R&D & Chief Scientific Of gave up 4,426 shares (to pay taxes)
- 4 Grant or award Chief Tech. Operations Officer acquired 25,000 shares (grant or award)
- 4 Shares withheld for taxes EVP & Chief Strategy Officer gave up 3,987 shares (to pay taxes)
- 4 Grant or award SVP, Head of Global Commercial acquired 12,500 shares (grant or award)
- 4 Shares withheld for taxes EVP & Chief R & QA Officer gave up 4,437 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 4,279 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 65,000 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 19,300 shares at an average $35.26 ($680,534)
Page 19 of 33 · 645 filings